$ACAN
AmeriCann, Inc. Stock $acan

$acan Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000143774919017129 Filed on August 19, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$11.56K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.016M	$510.5K	$430.0K
YoY Change	280.3%	18.72%	7.5%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$230.00	$230.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$2.016M	$510.5K	$434.3K
YoY Change	280.3%	17.54%	9.39%
Operating Profit		-$510.5K	-$434.3K
YoY Change		17.54%	12.22%
Interest Expense	-$270.8K	-$45.73K	$830.2K
YoY Change	-15.36%	-105.51%	1769.28%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$45.73K	-$851.7K
YoY Change		-94.63%	951.31%
Pretax Income	-$3.252M	-$556.3K	-$1.290M
YoY Change	282.59%	-56.88%	174.47%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.252M	-$556.2K	-$1.286M
YoY Change	282.59%	-56.75%	174.75%
Net Earnings / Revenue	-28131.49%
Basic Earnings Per Share
Diluted Earnings Per Share	-$139.2K	-$24.18K	-$66.32K
COMMON SHARES
Basic Shares Outstanding	23.41M	23.01M	19.45M
Diluted Shares Outstanding		23.01M	19.45M

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$465.8K	$3.440K	$1.010M
YoY Change	132.92%	-99.66%	10000.0%
Cash & Equivalents	$455.8K	$3.437K	$1.006M
Short-Term Investments
Other Short-Term Assets	$897.8K	$63.51K	$370.0K
YoY Change	-76.92%	-82.84%	311.11%
Inventory
Prepaid Expenses
Receivables	$11.56K
Other Receivables	$32.27K
Total Short-Term Assets	$1.407M	$93.94K	$1.375M
YoY Change	-65.52%	-93.17%	1273.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.573M	$6.389M	$6.074K
YoY Change	130600.52%	105092.79%	36.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.669M	$2.684M	$2.740M
YoY Change	-2.23%	-2.05%	-45.74%
Total Long-Term Assets	$10.36M	$9.985M	$4.599M
YoY Change	92.72%	117.12%	-30.48%
TOTAL ASSETS
Total Short-Term Assets	$1.407M	$93.94K	$1.375M
Total Long-Term Assets	$10.36M	$9.985M	$4.599M
Total Assets	$11.77M	$10.08M	$5.974M
YoY Change	24.41%	68.71%	-11.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$265.3K	$552.3K	$60.00K
YoY Change	-1.75%	820.55%	-84.62%
Accrued Expenses	$121.9K	$55.50K	$10.00K
YoY Change	143.76%	455.0%
Deferred Revenue
YoY Change
Short-Term Debt	$385.0K	$615.5K	$520.0K
YoY Change	-25.96%	18.36%	-47.47%
Long-Term Debt Due		$1.766M
YoY Change
Total Short-Term Liabilities	$781.3K	$3.034M	$610.6K
YoY Change	-7.52%	396.91%	-56.26%
LONG-TERM LIABILITIES
Long-Term Debt	$4.874M	$0.00	$1.960M
YoY Change	173.82%	-100.0%	-1.01%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.874M	$0.00	$1.960M
YoY Change	173.82%	-100.0%	-1.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$781.3K	$3.034M	$610.6K
Total Long-Term Liabilities	$4.874M	$0.00	$1.960M
Total Liabilities	$5.655M	$3.034M	$2.573M
YoY Change	115.27%	17.91%	-23.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.01M	-$14.76M	-$12.26M
YoY Change	37.41%	20.41%	65.61%
Common Stock	$2.351K	$2.327K	$2.044K
YoY Change	6.33%	13.85%	5.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.111M	$7.045M	$3.401M
YoY Change
Total Liabilities & Shareholders Equity	$11.77M	$10.08M	$5.974M
YoY Change	24.41%	68.71%	-11.04%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$3.252M	-$556.2K	-$1.286M
YoY Change	282.59%	-56.75%	174.75%
Depreciation, Depletion And Amortization	$230.00	$230.00	$0.00
YoY Change
Cash From Operating Activities	-$1.128M	-$166.6K	-$320.0K
YoY Change	121.14%	-47.94%	-8.57%
INVESTING ACTIVITIES
Capital Expenditures	-$1.184M	-$2.004M	-$190.0K
YoY Change	141.55%	954.55%	-26.92%
Acquisitions
YoY Change
Other Investing Activities	$6.010K	$10.54K	$0.00
YoY Change	-160.1%		-100.0%
Cash From Investing Activities	-$1.178M	-$1.993M	-$190.0K
YoY Change	135.52%	949.01%	-13.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.591M	395.0K	950.0K
YoY Change	-3.21%	-58.42%	156.76%
NET CHANGE
Cash From Operating Activities	-1.128M	-166.6K	-320.0K
Cash From Investing Activities	-1.178M	-1.993M	-190.0K
Cash From Financing Activities	3.591M	395.0K	950.0K
Net Change In Cash	1.286M	-1.765M	440.0K
YoY Change	-52.39%	-501.07%	-320.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.128M	-$166.6K	-$320.0K
Capital Expenditures	-$1.184M	-$2.004M	-$190.0K
Free Cash Flow	$55.78K	$1.837M	-$130.0K
YoY Change	-378.9%	-1513.13%	44.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	33435
CY2018Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	36926
	us-gaap	Interest Expense Other InterestExpenseOther	2009192
	acan	Amortization Of Equity Instruments Issued To Lessor AmortizationOfEquityInstrumentsIssuedToLessor	29595
	acan	Amortization Of Equity Instruments Issued To Lessor AmortizationOfEquityInstrumentsIssuedToLessor	28979
CY2019Q2	acan	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	5450650
CY2019Q2	acan	Class Of Warrant Or Right Exercisable Aggregate Intrinsic Value ClassOfWarrantOrRightExercisableAggregateIntrinsicValue	247203
CY2019Q2	acan	Class Of Warrant Or Right Exercisable Exercise Price ClassOfWarrantOrRightExercisableExercisePrice	1.94
	acan	Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm	P2Y36D
	acan	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	388000
	acan	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	1.23
CY2018Q3	acan	Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
CY2019Q2	acan	Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue	1048003
CY2018	acan	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P2Y219D
	acan	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P2Y73D
	acan	Debt Discount Related To Warrants Issued With Debt And Beneficial Conversion Feature DebtDiscountRelatedToWarrantsIssuedWithDebtAndBeneficialConversionFeature	0
	acan	Debt Discount Related To Warrants Issued With Debt And Beneficial Conversion Feature DebtDiscountRelatedToWarrantsIssuedWithDebtAndBeneficialConversionFeature	2297438
CY2019Q2	acan	Debt Instrument Related Parties Unamortized Discount Noncurrent DebtInstrumentRelatedPartiesUnamortizedDiscountNoncurrent	0
CY2018Q3	acan	Debt Instrument Related Parties Unamortized Discount Noncurrent DebtInstrumentRelatedPartiesUnamortizedDiscountNoncurrent	25673
CY2019Q2	acan	Debt Instrument Related Parties Unamortized Premium Current DebtInstrumentRelatedPartiesUnamortizedPremiumCurrent	9650
CY2018Q3	acan	Debt Instrument Related Parties Unamortized Premium Current DebtInstrumentRelatedPartiesUnamortizedPremiumCurrent	0
CY2019Q2	acan	Depoists On Land Noncurrent DepoistsOnLandNoncurrent	2680618
CY2018Q3	acan	Depoists On Land Noncurrent DepoistsOnLandNoncurrent	2724088
	acan	Increase Decrease In Interest Payable Related Party Net IncreaseDecreaseInInterestPayableRelatedPartyNet	25993
	acan	Increase Decrease In Interest Payable Related Party Net IncreaseDecreaseInInterestPayableRelatedPartyNet	-71064
CY2019Q2	acan	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	25993
CY2018Q3	acan	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	12742
CY2019Q2	acan	Notes And Other Receivables Net NotesAndOtherReceivablesNet	911694
CY2018Q3	acan	Notes And Other Receivables Net NotesAndOtherReceivablesNet	960669
CY2019Q2	acan	Notes And Other Receivables Net Current NotesAndOtherReceivablesNetCurrent	26990
CY2018Q3	acan	Notes And Other Receivables Net Current NotesAndOtherReceivablesNetCurrent
CY2019Q2	acan	Notes Loans And Financing Receivable Net Related Parties Noncurrent NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent	127789
CY2018Q3	acan	Notes Loans And Financing Receivable Net Related Parties Noncurrent NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent	176764
CY2014Q1	acan	Ownership Percentage Transfered OwnershipPercentageTransfered	0.93
	acan	Proceeds From Sale Of Land Used To Satisfy Debt Obligations ProceedsFromSaleOfLandUsedToSatisfyDebtObligations	0
	acan	Proceeds From Sale Of Land Used To Satisfy Debt Obligations ProceedsFromSaleOfLandUsedToSatisfyDebtObligations	1608451
	acan	Proceeds From Warrant Exercises Net ProceedsFromWarrantExercisesNet	475500
	acan	Proceeds From Warrant Exercises Net ProceedsFromWarrantExercisesNet	225000
CY2019Q2	acan	Security Deposit And Other Noncurrent Assets SecurityDepositAndOtherNoncurrentAssets	3110
CY2018Q3	acan	Security Deposit And Other Noncurrent Assets SecurityDepositAndOtherNoncurrentAssets	3110
	acan	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	388000
CY2018Q2	acan	Stock Issued During Period Value Issued For Cash Net StockIssuedDuringPeriodValueIssuedForCashNet	922412
CY2018Q4	acan	Stock Issued During Period Value Issued For Cash Net StockIssuedDuringPeriodValueIssuedForCashNet	650000
CY2019Q1	acan	Stock Issued During Period Value Issued For Cash Net StockIssuedDuringPeriodValueIssuedForCashNet	304001
CY2019Q2	acan	Stock Issued During Period Value Issued For Cash Net StockIssuedDuringPeriodValueIssuedForCashNet	110000
CY2018Q2	acan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	225000
CY2018Q4	acan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	395500
CY2019Q1	acan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	25000
CY2019Q2	acan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	55000
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001508348
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23410086
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Americann, Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23264356
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21803504
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19937606
CY2018Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent
CY2019Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	552328
CY2018Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	268065
CY2019Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	26783
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6489
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1309822
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1487438
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	810000
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	171307
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	135354
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	126126
CY2019Q2	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	977770
CY2018Q3	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	977770
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	123217
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1840745
CY2019Q2	us-gaap	Assets Assets	10078768
CY2018Q3	us-gaap	Assets Assets	9457421
CY2019Q2	us-gaap	Assets Current AssetsCurrent	93938
CY2018Q3	us-gaap	Assets Current AssetsCurrent	4082378
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3437
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	198144
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4016949
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1627
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4010460
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1308195
CY2018Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.55
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.56
CY2019Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3640000
CY2018Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9478650
CY2019Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9090650
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23264356
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22106763
CY2018Q2	us-gaap	Interest Expense Other InterestExpenseOther	830204
	us-gaap	Interest Expense Other InterestExpenseOther	182573
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22106763
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	2327
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4970
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-11990
CY2019Q2	us-gaap	Interest Expense Other InterestExpenseOther	19449
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	2211
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	261513
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	802741
CY2019Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0
CY2018Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	138750
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	922
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11218
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2019Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	199058
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	357224
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	716261
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1149678
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	298138
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-536217
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	40838
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4415
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	27849
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	26783
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	-10000
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	8848
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8997
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	100306
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	110777
	us-gaap	Interest Paid Net InterestPaidNet	129254
	us-gaap	Interest Paid Net InterestPaidNet	322438
CY2019Q2	us-gaap	Interest Payable Current InterestPayableCurrent	55500
CY2018Q3	us-gaap	Interest Payable Current InterestPayableCurrent	46605
CY2019Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	7150
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	15453
	us-gaap	Investment Income Interest InvestmentIncomeInterest	22239
	us-gaap	Investment Income Interest InvestmentIncomeInterest	40839
CY2019Q2	us-gaap	Liabilities Liabilities	3034151
CY2018Q3	us-gaap	Liabilities Liabilities	2627145
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10078768
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9457421
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3034151
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	844826
CY2019Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	37832
CY2018Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	9300
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	98878
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	13049
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1734501
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3416485
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4684199
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-214951
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1060762
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1893339
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-556245
	us-gaap	Net Income Loss NetIncomeLoss	-1651673
	us-gaap	Net Income Loss NetIncomeLoss	-3582652
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-1286020
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-1374364
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-922268
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-538508
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-556920
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45734
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-851677
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-263670
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2081991
CY2019Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	26990
CY2018Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2019Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	783905
CY2018Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	783905
CY2019Q2	us-gaap	Notes Payable Current NotesPayableCurrent	615490
CY2018Q3	us-gaap	Notes Payable Current NotesPayableCurrent	521250
CY2019Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1766296
CY2018Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2019Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent
CY2018Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1782319
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	510511
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	434343
	us-gaap	Operating Expenses OperatingExpenses	1388003
	us-gaap	Operating Expenses OperatingExpenses	1500661
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-510511
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-434343
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1388003
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1500661
CY2019Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17754
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8906
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3030
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2861
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	4706184
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	214951
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2019Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2500
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7470
CY2019Q2	us-gaap	Prepaid Rent PrepaidRent	57959
CY2018Q3	us-gaap	Prepaid Rent PrepaidRent	57959
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	21985
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1064001
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	922412
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	230000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2536000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18750
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	475500
CY2019Q2	us-gaap	Professional Fees ProfessionalFees	273621
CY2018Q2	us-gaap	Professional Fees ProfessionalFees	67819
	us-gaap	Professional Fees ProfessionalFees	572864
	us-gaap	Professional Fees ProfessionalFees	337934
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	35000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	285677
CY2019Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3052
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3818805
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.50
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19396514
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	150000
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14761214
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13109541
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
	us-gaap	Share Based Compensation ShareBasedCompensation	65000
	us-gaap	Share Based Compensation ShareBasedCompensation	432787
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	150000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	150000
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.21
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.50
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	150000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.50
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y328D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y36D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y36D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y36D
CY2018Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	65000
CY2018Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	802741
CY2018Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	46992
CY2019Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	30000
CY2019Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	184521
CY2018Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	65000
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	18750
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	7044617
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	6830276
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	2284300
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2568681
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	2610517
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	3400776
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	7449260
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	7251341
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2018Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23005753
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19447377
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22858359
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19396514
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23005753
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19447377
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22858359
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19396514
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23005753
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19447377
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22858359

Files In Submission

Name	View Source	Status
0001437749-19-017129-index-headers.html	Edgar Link	pending
0001437749-19-017129-index.html	Edgar Link	pending
0001437749-19-017129.txt	Edgar Link	pending
0001437749-19-017129-xbrl.zip	Edgar Link	pending
acan-20190630.xml	Edgar Link	completed
acan-20190630.xsd	Edgar Link	pending
acan-20190630_cal.xml	Edgar Link	unprocessable
acan-20190630_def.xml	Edgar Link	unprocessable
acan-20190630_lab.xml	Edgar Link	unprocessable
acan-20190630_pre.xml	Edgar Link	unprocessable
acan20190630_10q.htm	Edgar Link	pending
ex_154522.htm	Edgar Link	pending
ex_154523.htm	Edgar Link	pending
ex_154524.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACAN
AmeriCann, Inc. Stock $acan

2019 Q3 Form 10-Q Financial Statement

#000143774919017129 Filed on August 19, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACAN AmeriCann, Inc. Stock $acan

2019 Q3 Form 10-Q Financial Statement

#000143774919017129 Filed on August 19, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACAN
AmeriCann, Inc. Stock $acan